China National Medicines Corporation(600511) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Sinopharm Co., Ltd.: Sinopharm Stock Report for the First Quarter of 2025
SZSI12:00 ET · Announcements
China National Medicines Corporation's First Quarter Report for 2025.
SZSI12:00 ET · Announcements
China National Medicines Corporation (600511.SH) released its first quarter performance, reporting a Net income of 0.459 billion yuan, a year-on-year decline of 0.1%.
China National Medicines Corporation (600511.SH) released its first quarter report for 2025, with revenue of 12...
Zhitong FinanceApr 24 07:25 ET
Express News | China National Medicines Corp Q1 Net Profit Down 0.1%
ReutersApr 24 05:55 ET
China National Medicines Corporation Ltd.'s (SHSE:600511) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Simply Wall StApr 8 01:28 ET
China National Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Simply Wall StMar 21 19:00 ET

Comments

Moomoo AI

Mar 8, 2024 07:10

China National Medicines' falling ROCE and high dependence on short-term creditors could worry potential investors. The modest 32% stock gain over five years may reflect these concerns. The firm's reinvestment despite declining returns may not bode well for multi-bagger investors.

China National Medicines (SHSE:600511) Might Be Having Difficulty Using Its Capital Effectively

Moomoo AI

Dec 1, 2023 08:10

China National Medicines' reinvestment of capital hasn't significantly boosted sales and may take more time to positively impact earnings. Its declining ROCE and high liabilities make it an unlikely multi-bagger, suggesting investors look elsewhere.

China National Medicines (SHSE:600511) Will Be Hoping To Turn Its Returns On Capital Around

600511 China National Medicines Corporation

Trade Overview

Capital Trend

News

Comments

Market Insights

Market Headlines

Latest News